about
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantationMolecular Mechanisms to Control Post-Transplantation Hepatitis B RecurrenceHyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation.Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experience.Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxisIntravenous immunoglobulins in liver transplant patients: Perspectives of clinical immune modulation.Liver transplantation in adults: Choosing the appropriate timingStrategies for the prevention of infection after solid organ transplantation.Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation?Immunotherapeutic potential of neutralizing antibodies targeting conserved regions of the HCV envelope glycoprotein E2.Emerging pipeline drugs for hepatitis B infection.Liver transplantation for hepatitis B liver disease and concomitant hepatocellular carcinoma in the United States With hepatitis B immunoglobulin and nucleoside/nucleotide analogues.Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity.Safe and cost-effective control of post-transplantation recurrence of hepatitis B.Efficacy and effectiveness of anti-HBV therapy with early withdrawal of HBIG prophylaxis to prevent HBV recurrence following liver transplantation.Posttransplantation prophylaxis with primary high-dose hepatitis B immunoglobulin monotherapy and complementary preemptive antiviral add-on.Hepatitis B immunoglobulin prophylaxis after liver transplantation: experience in a tertiary transplant centreClinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.Adult-to-adult right-lobe living donor liver transplantation in recipients with hepatitis B virus-related benign liver disease and high model end-stage liver disease scores.A novel model for evaluating the risk of hepatitis B recurrence after liver transplantation.Review article: hepatitis B core-related antigen (HBcrAg): an emerging marker for chronic hepatitis B virus infection.Anti-hepatitis B surface immunoglobulin reduction in early postoperative period after liver transplantation in hepatitis B virus-positive patients.Recipient cytotoxic T lymphocyte antigen-4 +49 G/G genotype is associated with reduced incidence of hepatitis B virus recurrence after liver transplantation among Chinese patients.Favorable outcome of liver transplantation despite a high hepatitis B virus replication: beyond the limits?Case report of lamivudine-resistant hepatitis B virus infection post liver transplantation from a hepatitis B core antibody donor.
P2860
Q26784241-57B380AD-26B8-4D26-893D-5A40D96A3F82Q26799246-726D1092-DF6D-4109-BA22-BC96AC425E05Q33624284-96F645D6-34B4-45BF-9605-DEA39A27ECD3Q34029115-519A63B4-0A40-41DB-90F5-FC6890CAF40BQ35549423-31F5D429-4222-498D-BC5C-2AC3941A80B9Q35715908-15FC91B2-7DD3-4DF9-8ECD-50AA728235FAQ36220176-376C8F7E-A6A9-4117-B9DB-A036791B37D3Q36670902-84128F3A-4D60-4719-8145-577344184527Q37468277-B6F329F0-E172-45FA-9B56-7410FB7D8F34Q37859393-176B1938-7A06-45C8-B5AE-B06A4E3FC6BBQ37971052-6A87A69A-EFAC-4AEA-88DF-6C9E322B2B26Q38121508-1EE2A045-510A-4C4B-AFB5-1CCCC43B2E43Q38137238-C7BDEF72-1EC8-4347-BB97-CB684E727794Q38218260-889F254E-7E74-4540-95EB-1A40E4F6F47CQ38417238-5BDD1052-E87F-4124-8270-5590FA2F3F8BQ38475751-A8C4072D-B5D5-4132-9522-8057F360CA8AQ41835680-2D0EA6BA-9661-4F54-8430-6CF7D77A9482Q42244681-DE7A02A0-4229-4C05-A59F-715B6101D953Q43782103-A3954282-9AF4-48E3-9C8E-5CC8F26F585BQ44179156-00AEF3FA-E47C-4998-9313-FB9121B1022CQ45326295-EC6893B0-DC61-4C3C-886A-F6D195F3FA84Q45362944-B79CF157-1493-47FE-9252-9DB40640D2A1Q45399816-31AC271D-D597-43E3-B65A-00CC90D6EB12Q45413279-F1864960-2DB0-4B8F-B5D6-D9CEF09DE099Q45417753-53D72B50-3FB3-49A7-A711-4A26BC809483
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Evolving strategies to prevent HBV recurrence.
@ast
Evolving strategies to prevent HBV recurrence.
@en
type
label
Evolving strategies to prevent HBV recurrence.
@ast
Evolving strategies to prevent HBV recurrence.
@en
prefLabel
Evolving strategies to prevent HBV recurrence.
@ast
Evolving strategies to prevent HBV recurrence.
@en
P356
P1476
Evolving strategies to prevent HBV recurrence
@en
P2093
Bruno Roche
P304
P356
10.1002/LT.20258
P433
10 Suppl 2
P577
2004-10-01T00:00:00Z